Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Plerixafor for Poorly Mobilized Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE4
The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of People With CD30 Positive Lymphoma in China
- Status
- COMPLETED
- Phase
- N/A
Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker
- Status
- RECRUITING
- Phase
- N/A
A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type
- Status
- RECRUITING
- Phase
- PHASE2
Feasibility of Combined Genomics/Transcriptomics for Patients With Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
- Status
- RECRUITING
- Phase
- NA
A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
- Status
- RECRUITING
- Phase
- N/A
Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2
SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study Evaluating the Safety, Tolerability, Pharmacokinetic and Efficacy of HLX301(TIGIT×PDL1 Bispecific) in Locally Advanced/Metastatic Solid Tumors or Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2